Patent details

EP3297631 Title: NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF HOT FLUSHES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3297631
WO Application Number:
EP2016060945
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16723107.5
WO Publication Number:
WO2016184829
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
16/05/2016
Grant date:
04/09/2019
EP Publication Date:
28/03/2018
WO Publication Date:
24/11/2016
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/11/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/09/2019
EP B1 Publication Date:
04/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
15/05/2036
Lapsed By Expiration Date:
Patent Validated Date:
23/11/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
12/02/2021
 
 

 

Name:
KANDY THERAPEUTICS LIMITED
Address:
400 South Oak Way, RG2 6AD, Reading, Berkshire, United Kingdom (GB)

Historical Applicant/holder

From:
04/09/2019
To:
12/02/2021

 

Name:
NeRRe Therapeutics Limited
Address:
Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, United Kingdom (GB)

Agent

Name:
ir. J.D. de Zeeuw
From:
22/11/2019
Address:
Murgitroyd & Company Scotland House 165 - 169 Scotland Street, G5 8PL, Glasgow, United Kingdom (GB)
To:

Inventor

Name:
TROWER, Mike
Address:
Stevenage Hertfordshire SG1 2FX, United Kingdom (GB)

Priority

Priority Patent Number:
201562162870 P
Priority Date:
18/05/2015
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/5383; A61P 5/24; A61P 43/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
08/21
Publication date:
24/02/2021
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
48/19
Publication date:
27/11/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
36/19
Publication date:
04/09/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201936
Publication date:
04/09/2019
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202100312A
Date Registered:
12/02/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.D. de Zeeuw
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
KANDY THERAPEUTICS LIMITED
Address:
400 South Oak Way, RG2 6AD, Reading, Berkshire, United Kingdom (GB)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
11
Annual Fee Amount:
500 Euro
Last Annual Payment Date:
25/04/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
22/11/2019 Outgoing Correspondence Letter no formal defects 1 PDF /9/5/1/6/5/0800456159/docs/ep16723107.5_1_311960l271.pdf
06/11/2019 Claims First filed claims 2 PDF /9/5/1/6/5/0800456159/docs/ep16723107.5_0_claims20191106124501909.pdf